Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., 569 U.S. 12-398 (13 June 2013) | United Nations

Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., 569 U.S. 12-398 (13 June 2013)

Case Description

The U.S. Supreme Court decided on 13 June 2013 unanimously that isolated naturally occurring genes are not patent eligible subject matter. Synthetically created composite DNA, however, is patent eligible.

Decision Year

2013

Case Summary

Document

Association for Molecular Pathology et al. v. Myriad Genetics, U.S. Supreme Court 2013.pdf

Decision Link

https://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf

Pre-grant flexibilities

Patentable subject matter (invention)

Keywords

Jurisdiction

United States of America